Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-na ïve and non-naïve patients

ConclusionsIn clinical practice, ADA was effective in UC, especially in anti-TNF na ïve patients. FC and CRP could be predictors of treatment effectiveness.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Gastroenterology